HomeInsightsResults

Metropolis Healthcare Ltd Quarterly Result

Metropolis Healthcare Ltd Quarterly Result

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

1.4 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Metropolis Healthcare Ltd

NSE: METROPOLIS

Net Profit

₹ 46.7

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of Metropolis Healthcare Ltd for the Sep '24 is ₹ 352.92 crore as compare to the Jun '24 revenue of ₹ 315.81 crore. This represent the growth of 11.750741%.
  • The ebitda of Metropolis Healthcare Ltd for the Sep '24 is ₹ 93.01 crore as compare to the Jun '24 ebitda of ₹ 81.27 crore. This represent the growth of 14.445682%.
  • The net profit of Metropolis Healthcare Ltd for the Sep '24 is ₹ 46.7 crore as compare to the Jun '24 net profit of ₹ 38.11 crore. This represent the growth of 22.540016%.

Results Analysis

Market Price of Metropolis Healthcare Ltd

1M

1Y

3Y

5Y

Monitoring Metropolis Healthcare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20242062.1
21 Nov 20242016.2
19 Nov 20242016.95
18 Nov 20242023.95
14 Nov 20242033.3
13 Nov 20242051.05
12 Nov 20242173.3
11 Nov 20242155.1
08 Nov 20242115.2
07 Nov 20242112.6

Historical Revenue of Metropolis Healthcare Ltd

No data available

* All values are in crore

Historical EBITDA of Metropolis Healthcare Ltd

No data available

* All values are in crore

Historical Net Profit of Metropolis Healthcare Ltd

No data available

* All values are in crore

Metropolis Healthcare Ltd News Hub

News

Metropolis Healthcare Q2 PAT jumps 31% YoY to Rs 47 cr

Revenue from operations grew 13.38% YoY to Rs 349.79 crore in the quarter ended 30 Septemb...

Read more

09 Nov 202412:02

News

Metropolis Healthcare to convene board meeting

Metropolis Healthcare will hold a meeting of the Board of Directors of the Company on 8 No...

Read more

02 Nov 202413:57

News

Metropolis Healthcare declare Quarterly Result

Metropolis Healthcare will hold a meeting of the Board of Directors of the Company on 8 No...

Read more

31 Oct 202414:21

News

Metropolis Healthcare CFO Rakesh Agarwal resigns

Metropolis Healthcare is a diagnostics company, with presence in 23 states & 601 towns. In...

Read more

14 Oct 202408:36

News

Metropolis' revenue climbs 13% YoY in Q2

Revenue growth was driven by patient volume growth, test volume growth and change in produ...

Read more

07 Oct 202411:12

News

Metropolis Healthcare to discuss results

Metropolis Healthcare will hold a meeting of the Board of Directors of the Company on 10 A...

Read more

08 Aug 202416:20

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

FAQ's For Metropolis Healthcare Ltd Quarterly Result

What is the EPS of Metropolis Healthcare Ltd stock?

The Earnings Per Share (EPS) of Metropolis Healthcare Ltd is 28.87. An EPS is the amount of net income attributed to each share of a common stock.

How is Metropolis Healthcare Ltd EPS calculated?

The EPS of Metropolis Healthcare Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Metropolis Healthcare Ltd report its EPS?

Metropolis Healthcare Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Metropolis Healthcare Ltd EPS?

Factors that influence the EPS of Metropolis Healthcare Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Metropolis Healthcare Ltd EPS growth indicate future performance?

Yes, consistent growth in Metropolis Healthcare Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*